Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Circulation

• Publication date

  2004-11-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000148370.60535.22PMID 15545514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ceramide Synthesis Correlates with the Posttranscriptional Regulation of the Sterol-Regulatory Element-Binding Protein

  2004cited by this paper
• Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage*

  2003cited by this paper
• Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.

  2002cited by this paper
• Lysophospholipid regulation of mononuclear phagocytes.

  2002cited by this paper
• Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

  2002cited by this paper
• Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.

  2002cited by this paper
• Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

  2002cited by this paper
• SPTLC1 is mutated in hereditary sensory neuropathy, type 1

  2001cited by this paper
• Cell Cycle Progression and Cell Polarity Require Sphingolipid Biosynthesis in Aspergillus nidulans

  2001cited by this paper
• Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I

  2001cited by this paper
• Acid Sphingomyelinase-deficient Macrophages Have Defective Cholesterol Trafficking and Efflux*

  2001cited by this paper
• Quantitative determination of ceramide using diglyceride kinase.

  2000cited by this paper
• Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease

  2000cited by this paper
• Tsc3p Is an 80-Amino Acid Protein Associated with Serine Palmitoyltransferase and Required for Optimal Enzyme Activity*

  2000cited by this paper
• De Novo Synthesis of Sphingolipids Is Required for Cell Survival by Down-Regulating c-Jun N-Terminal Kinase inDrosophila Imaginal Discs

  1999cited by this paper
• Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.

  1998cited by this paper
• Rapid separation and quantitation of combined neutral and polar lipid classes by high-performance liquid chromatography and evaporative light-scattering mass detection.

  1998cited by this paper
• Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pH

  1998cited by this paper
• Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions.

  1998cited by this paper
• A Mammalian Homolog of the Yeast LCB1 Encodes a Component of Serine Palmitoyltransferase, the Enzyme Catalyzing the First Step in Sphingolipid Synthesis*

  1997cited by this paper
• Human and murine serine-palmitoyl-CoA transferase--cloning, expression and characterization of the key enzyme in sphingolipid synthesis.

  1997cited by this paper
• Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.

  1996cited by this paper
• Sphingomyelin Inhibits the Lecithin-Cholesterol Acyltransferase Reaction with Reconstituted High Density Lipoproteins by Decreasing Enzyme Binding*

  1996cited by this paper
• Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.

  1995cited by this paper
• The response-to-retention hypothesis of early atherogenesis.

  1995cited by this paper
• Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite.

  1994cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel filtration chromatography.

  1991cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Nonoptimal Temperature Exposure and Sphingolipid Metabolism: Implications for Cardiovascular Risk.

  2025cites this paper
• Sphingomyelin synthase-related protein is a regulator of serine palmitoyltransferase

  2025cites this paper
• Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis

  2025cites this paper
• Differential effects of PCSK9 inhibitors and statins on plasma ceramides in coronary artery disease

  2025cites this paper
• Chronic Real-Ambient PM2.5 Exposure Exacerbates Cardiovascular Risk via Amplifying Liver Injury in Mice Fed with a High-Fat and High-Cholesterol Diet

  2024cites this paper
• Sphingolipid-Induced Bone Regulation and Its Emerging Role in Dysfunction Due to Disease and Infection

  2024cites this paper
• Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?

  2024cites this paper
• Diet-Induced Severe Hyperhomocysteinemia Promotes Atherosclerosis Progression and Dysregulates the Plasma Metabolome in Apolipoprotein-E-Deficient Mice

  2024cites this paper
• Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis.

  2024cites this paper
• Atypical sphingosine-1-phosphate metabolites—biological implications of alkyl chain length

  2024cites this paper
• Ceramides are Fuel Gauges on the Drive to Cardiometabolic Disease.

  2024cites this paper
• Lipids associated with atherosclerotic plaque instability revealed by mass spectrometry imaging of human carotid arteries.

  2024cites this paper
• Ceramides and mitochondrial homeostasis.

  2024cites this paper
• Substitution of dietary monounsaturated fatty acids from olive oil for saturated fatty acids from lard increases LDL apolipoprotein B-100 fractional catabolic rate in subjects with dyslipidemia associated with insulin resistance: a randomized controlled trial.

  2024cites this paper
• The First Japanese Case of Familial Hypercholesterolemia Caused by an apolipoprotein E (APOE) p.Leu167del Mutation

  2024cites this paper
• Impact of HepG2 Cells Glutathione Depletion on Neutral Sphingomyelinases mRNA Levels and Activity

  2023cites this paper
• Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate

  2023cites this paper
• Metabolic Signatures Elucidate the Effect of Body Mass Index on Type 2 Diabetes

  2023cites this paper
• Effect of Total SMS (Sphingomyelin Synthase) Activity on LDL (Low-Density Lipoprotein) Catabolism in Mice.

  2023cites this paper
• Identifying lipid traces of atherogenic mechanisms in human carotid plaque.

  2023cites this paper
• The Role of Lipid Subcomponents in the Development of Atherosclerotic Plaques

  2023cites this paper
• Effect of Total Sphingomyelin Synthase Activity on Low Density Lipoprotein Catabolism in Mice

  2023cites this paper
• Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response

  2022cites this paper
• Sphingolipids and Cholesterol.

  2022cites this paper
• Crosstalk Between Adipose Tissue and the Heart: An Update

  2022cites this paper
• Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease

  2022cites this paper
• De Novo Sphingolipid Biosynthesis in Atherosclerosis.

  2022cites this paper
• Spatial metabolomics identifies lipid profiles of human carotid atherosclerosis.

  2022cites this paper
• Ceramide Acyl Chain Length and Its Relevance to Intracellular Lipid Regulation

  2022cites this paper
• Sphingolipid metabolism and signaling in cardiovascular diseases

  2022cites this paper
• Ambient Air Pollution and Atherosclerosis: A Potential Mediating Role of Sphingolipids

  2022cites this paper
• Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR−/− mice

  2022cites this paper
• Inhibitory Effects of Myriocin on Non-Enzymatic Glycation of Bovine Serum Albumin

  2022cites this paper
• The Complex Tail of Circulating Sphingolipids in Atherosclerosis and Cardiovascular Disease

  2021cites this paper
• Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?

  2021cites this paper
• Lysosome (Dys)function in Atherosclerosis—A Big Weight on the Shoulders of a Small Organelle

  2021cites this paper
• Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease

  2021cites this paper
• Mass Spectrometry Imaging as a Tool to Investigate Region Specific Lipid Alterations in Symptomatic Human Carotid Atherosclerotic Plaques

  2021cites this paper
• Ceramides and other sphingolipids as drivers of cardiovascular disease

  2021cites this paper
• Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology

  2021cites this paper
• Ceramide Scores Predict Cardiovascular Risk in the Community

  2021cites this paper
• Mass Spectrometry Imaging as a Tool to Investigate Region Specific Lipid Alterations in Symptomatic Human Carotid Atherosclerotic Plaques

  2021cites this paper
• Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease.

  2020cites this paper
• Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes.

  2020cites this paper
• Alterations of endogenous sphingolipid metabolism in cardiometabolic diseases: towards novel therapeutic approaches.

  2020cites this paper
• Antioxidants

  2020cites this paper
• Associations between plasma ceramides and mortality in patients with coronary artery disease.

  2020cites this paper
• Analysis of the metabolic switch induced by the spirulina peptide SP6 in high fat diet ApoE-/- mice model: A direct infusion FT-ICR-MS based approach.

  2020cites this paper
• Ceramides in Metabolism: Key Lipotoxic Players.

  2020influential citation
• Time-restricted feeding prevents high-fat and high-cholesterol diet-induced obesity but fails to ameliorate atherosclerosis in apolipoprotein E-knockout mice

  2020cites this paper
• [Ceramids and their role in the development of cardiovascular diseases (review of literature).]

  2020cites this paper
• Sphingolipids in food and their critical roles in human health

  2020cites this paper
• Ceramides in Adipose Tissue

  2020cites this paper
• Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion

  2020cites this paper
• Insights into the prognosis of lipidomic dysregulation for death risk in patients with coronary artery disease

  2020cites this paper
• A Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating Lipoproteins

  2020cites this paper
• Myriocin and D-PDMP ameliorate atherosclerosis in ApoE-/-mice via reducing lipid uptake and vascular inflammation.

  2020cites this paper
• The antiatherosclerotic and antianxiety-like effects of the Cordyceps sobolifera mycelium in apoE deficient mice

  2019cites this paper
• Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation

  2019cites this paper
• Potential therapeutic targets for atherosclerosis in sphingolipid metabolism

  2019cites this paper
• Ceramides: Nutrient Signals that Drive Hepatosteatosis

  2019cites this paper
• Fermented Cordyceps militaris Extract Ameliorates Hepatosteatosis via Activation of Fatty Acid Oxidation

  2019cites this paper
• Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism

  2019cites this paper
• Sulforaphane Prevents Hepatic Insulin Resistance by Blocking Serine Palmitoyltransferase 3-Mediated Ceramide Biosynthesis

  2019cites this paper
• Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review

  2019cites this paper
• Untargeted Mass Spectrometry Lipidomics identifies correlation between serum sphingomyelins and plasma cholesterol

  2019cites this paper
• Sphingolipid Mediators of Myocardial Pathology

  2019cites this paper
• Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication

  2019cites this paper
• Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.

  2019cites this paper
• Metabolic Messengers: ceramides

  2019cites this paper
• Sphingolipid metabolism in non-alcoholic fatty liver diseases.

  2019cites this paper
• Sphingomyelin Synthase 2 Promotes Endothelial Dysfunction by Inducing Endoplasmic Reticulum Stress

  2019cites this paper
• Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis

  2018cites this paper
• nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe−/− Mice

  2018cites this paper
• Sphingolipid de novo biosynthesis is essential for intestine cell survival and barrier function

  2018cites this paper
• Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies.

  2018cites this paper
• Liquid chromatograph-mass spectrometry-based plasma metabonomics study on the effects of moxibustion with seed-sized moxa cone on hyperlipidaemia

  2018cites this paper
• Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance

  2017cites this paper
• Increased de novo ceramide synthesis and accumulation in failing myocardium.

  2017cites this paper
• Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea)

  2017cites this paper
• Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.

  2017cites this paper
• Ceramide dependent lipotoxicity in metabolic diseases

  2017cites this paper
• Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice

  2017cites this paper
• Sphingolipids in obesity and related complications.

  2017influential citation
• Increased de novo ceramide synthesis and accumulation in failing myocardium.

  2017cites this paper
• Specific Skeletal Muscle Sphingolipid Compounds in Energy Expenditure Regulation and Weight Gain in Native Americans of Southwestern Heritage

  2017cites this paper
• Sphingolipids, ORMDL3 and asthma: what is the evidence?

  2016cites this paper
• Hypothalamic Lipids: Key Regulators of Whole Body Energy Balance

  2016cites this paper
• Liver serine palmitoyltransferase activity deficiency in early life impairs adherens junctions and promotes tumorigenesis

  2016cites this paper
• Minireviews S 1 P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis

  2016cites this paper
• A Single In-Vial Dual Extraction Strategy for the Simultaneous Lipidomics and Proteomics Analysis of HDL and LDL Fractions.

  2016cites this paper
• Healthy Dietary Patterns, Plasma Lipid Metabolites, Cardiovascular Health and Mortality

  2016cites this paper
• Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase.

  2016cites this paper
• Pharmacological Activation of Peroxisome Proliferator-Activated Receptor {Delta} Increases Sphingomyelin Synthase Activity in THP-1 Macrophage-Derived Foam Cell

  2016cites this paper
• S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis

  2016cites this paper
• Chinese hamster ovary-sphingomyelin synthase2 biospecific extraction and liquid chromatography with tandem mass spectrometry analysis for the prediction of bioactive components of Rhizoma Polygoni Cuspidati.

  2016cites this paper
• Regulation of SREBPs by Sphingomyelin in Adipocytes via a Caveolin and Ras-ERK-MAPK-CREB Signaling Pathway

  2015cites this paper
• Sphingolipids in High Fat Diet and Obesity-Related Diseases

  2015cites this paper
• Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis

  2015cites this paper
• Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.

  2015cites this paper